期刊文献+

慢性血栓栓塞性肺动脉高压的流行病学

Epidemiology of chronic thromboembolic pulmonary hypertension
原文传递
导出
摘要 慢性血栓栓塞性肺动脉高压(CTEPH)属于肺动脉高压(PH)疾病分类中的第四大类型,是一种毛细血管前肺动脉高压。尽管CTEPH相对少见,因其有多种治疗方法和潜在治愈的可能性,尤其值得关注。早期识别、诊断并及时治疗,可以明显改善患者预后。文章将通过对CTEPH患病率、疾病危险因素、自然病程及预后几个方面进行总结探讨,以期进一步提高对疾病的认识。 Chronic thromboembolic pulmonary hypertension(CTEPH)is a kind of pre-capillary pulmonary hypertension(PH),which belongs to the 4th group of PH. Although CTEPH is relatively rare,it is of particular interest because of its multiple treatments and potential curability. Early identification and diagnosis and timely treatment can significantly improve the prognosis. This paper will summarize and discuss the prevalence,risk factors,natural course and prognosis of CTEPH in order to further improve the understanding of the disease.
作者 毛建军 杨媛华 龚娟妮 MAO Jian-jun;YANG Yuan-hua;GONG Juanni(Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital,Capital Medical University,Beijing Institute of Respiratory Medicine,Beijing 100020,China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2022年第12期978-981,986,共5页 Chinese Journal of Practical Internal Medicine
基金 2022年北京朝阳医院科技创新基金(22kcjjzd-1)。
关键词 慢性血栓栓塞性肺动脉高压 流行病学 患病率 自然病程 预后 chronic thromboembolic pulmonary hypertension epidemiology prevalence rates natural course prognosis
  • 相关文献

参考文献3

二级参考文献19

  • 1国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:78
  • 2Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J, 2001, 17:647-652.
  • 3Camargo VM, Martins Bdo C, Jardim C, et al. Validation of a treadmill six-minute walk test protocol for the evaluation of patients with pulmonary arterial hypertension. J Bras Pneumol, 2009, 35 : 423 -430.
  • 4Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology ( ESC ), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT) , et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J, 2009, 34: 1219-1263.
  • 5McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation TaskForce on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol, 2009, 53:1573-1619.
  • 6McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004, 126 : 14S-34S.
  • 7Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the Eurppean Society of Cardilogy. Eur Heart J, 2004, 25: 2243- 997R.
  • 8ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med, 2002, 166: 111- 117.
  • 9Berger RM, Beghetti M, Gali~ N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo- controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol, 2010, 144:373-378.
  • 10Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132: 373-379.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部